Dr. Ashraf Ibrahim Reyad, MD

Dr. Reyad practices at Medical City Fort Worth Hospital in Fort Worth, Texas, part of HCA Healthcare.

Dr. Reyad's NPI, 1518273986, was assigned on August 24, 2010. Dr. Reyad holds Pennsylvania license MD487046.

Dr. Reyad's primary practice is Medical City Fort Worth Hospital, at 900 Eighth Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 336-2100.

Dr. Reyad's primary practice is Medical City Fort Worth Hospital in Fort Worth, Texas, part of HCA Healthcare. Dr. Reyad is also affiliated with Lehigh Valley Hospital-Cedar Crest. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Reyad to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reyad practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Reyad's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dmand AI has Dr. Reyad's licenses on file in 3 states: Pennsylvania, Maryland and Texas.

CMS data shows 134 Medicare services from Dr. Reyad across 5 procedure codes in 2024, for 61 Medicare patients. Medicare paid $41,877 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Reyad in 2024. The largest group is under 65, with 35 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 8.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reyad's median patient age at 59, with 43% women.

In 2024, Dr. Reyad wrote 33 Medicare Part D claims for 17 patients. 82% of them were for generic drugs. They cover 7 drugs, with $2,353 in total drug cost. In 2022, CMS named 417 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Reyad for performance year 2024, reported through an alternative payment model (APM). Dr. Reyad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Reyad, published from 2014 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Acute Kidney Injury and COVID-19. Dr. Reyad has published most often in Cureus. Dr. Reyad's most frequent co-authors are Sridhar Reddy Allam, MD, MPH, Machaiah M. Madhrira, MD and Balamurugan Ponniah Sankarapandian, MD.

CMS Open Payments shows 16 general payments to Dr. Reyad from 10 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 50% of the total. Intuitive Surgical, Inc. paid the most, $895.